Core Viewpoint - The company, Guangzhou Kingmed Diagnostics Group Co., Ltd., anticipates a significant net loss for the fiscal year 2025, projecting a net profit attributable to shareholders of between -130 million yuan and -190 million yuan, indicating a year-on-year reduction in losses of 191.24 million yuan to 251.24 million yuan [2][3]. Group 1: Performance Forecast - The performance forecast period is from January 1, 2025, to December 31, 2025 [3]. - The company expects a net profit attributable to shareholders of between -130 million yuan and -190 million yuan for 2025, which represents a year-on-year reduction in losses of 191.24 million yuan to 251.24 million yuan [2][3]. - The projected net profit, excluding non-recurring gains and losses, is estimated to be between -120 million yuan and -180 million yuan [2][3]. Group 2: Previous Year Performance - In the previous year, the total profit was -438.65 million yuan, with a net profit attributable to shareholders of -381.24 million yuan [5]. - The net profit attributable to shareholders, excluding non-recurring gains and losses, was -237.98 million yuan [5]. - The basic earnings per share for the previous year were -0.82 yuan [6]. Group 3: Reasons for Expected Loss - The primary reasons for the expected loss include significant impairment provisions due to changes in the macro environment and the aging of accounts receivable, with an estimated credit impairment loss of approximately 350 million to 390 million yuan for 2025 [8]. - The operating environment has been impacted by economic cycles and macro policies, leading to pressure on short-term business development, while the company is optimizing its customer structure for better quality growth [8]. - Short-term adjustment costs related to management efficiency improvements and internal resource integration have led to increased expenses, affecting current operating performance [8]. - Increased investment in digital transformation is expected to raise operational costs in the short term but aims to drive future business growth [9].
金域医学发布2025年年度业绩预亏公告